Bone marrow transplantation with genetically modified cells may prolong the period of cancer-free survival, suggests a study led by Dr. Vivek Rangnekar, associate director of translational research for the Markey Cancer Center ...
Aug 24, 2011
0
0
New research offers insight into why regular, long-term use of low-dose aspirin may reduce the risk of death from colon and rectal cancers.
Mar 31, 2021
0
29
(HealthDay)—For patients with elevated lipoprotein(a) levels and established cardiovascular disease, hepatocyte-directed antisense oligonucleotide AKCEA-APO(a)-LRX (APO(a)-LRX) reduces lipoprotein(a) levels, according to ...
Jan 3, 2020
0
5
One test of both the power and hunger of any individual or organization is the ability to master any and every new, sufficiently advanced technological opportunity that urgently presents itself to the world at large. For ...
Blood clotting is the "Jekyll and Hyde" of biological processes. It's a lifesaver when you're bleeding, but gone awry, it causes heart attacks, strokes and other serious medical problems. If a clot grows too big, pieces dislodged ...
Nov 9, 2017
1
61
About 90 percent of cancer deaths are caused by secondary tumors, known as metastases, which spread from the original tumor site.
Nov 15, 2011
1
0
The Liquid Biopsy and Cancer Interception research group—part of the Biohealth Research Institute in Granada (ibs.GRANADA), in which researchers from the University of Granada (UGR) participate—has discovered that tumor ...
Mar 30, 2022
0
6
Patients who had undergone hemodialysis using dialyzers that had been sterilized with the use of electron beams were more likely to develop thrombocytopenia (an abnormally low platelet count in the blood, associated with ...
Oct 18, 2011
0
0
The trend in hospitals and guidelines is to be increasingly cautious with blood transfusions. Due to side effects associated with blood transfusion and the increasing scarcity and costs of blood products. For example, in ...
May 24, 2023
1
77
(HealthDay) -- The blockbuster drug Plavix (clopidogrel), used to prevent clotting in some heart patients, will go off patent in the United States on Thursday, making it considerably more affordable.
May 15, 2012
0
0
